Moxifloxacin Related Compound A
United States Pharmacopeia (USP) Reference Standard
Manufacturer: Sigma Aldrich
CAS Number: 151213-15-9
Synonym(S): 1-Cyclopropyl-6,8-difluoro-1,4-dihydro-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-3-quinolinecarboxylic acid
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| 25 MG | 1448617-25-MG | In Stock | ₹ 1,39,610.03 |
1448617 - 25 MG
In Stock
Quantity
1
Base Price: ₹ 1,39,610.03
GST (18%): ₹ 25,129.805
Total Price: ₹ 1,64,739.835
grade
pharmaceutical primary standard
API family
moxifloxacin
manufacturer/tradename
USP
application(s)
pharmaceutical (small molecule)
format
neat
InChI
1S/C20H21F2N3O3/c21-14-6-12-17(25(11-3-4-11)8-13(19(12)26)20(27)28)16(22)18(14)24-7-10-2-1-5-23-15(10)9-24/h6,8,10-11,15,23H,1-5,7,9H2,(H,27,28)/t10-,15+/m0/s1
InChI key
WEXQOLCYKFJAJZ-ZUZCIYMTSA-N
Other Options
| Image | Product Name | Manufacturer | Price Range | |
|---|---|---|---|---|
 | 8-Desmethoxy-8-fluoro Moxifloxacin | ChemScene | ₹ 9,753.84 - ₹ 1,56,574.80 | |
 | 151213-15-9 | 1-Cyclopropyl-6,8-difluoro-7-((4as,7as)-hexahydro-1h-pyrrolo[3,4-b]pyridin-6(2h)-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid | A2B Chem | ₹ 9,326.04 - ₹ 42,865.56 |
Related Products
Description
- General description: This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.
- Application: Optimization of separation and determination of moxifloxacin and its related substances by RP-HPLC: Demonstrating the analytical prowess of RP-HPLC, this research utilizes Moxifloxacin Related Compound A to refine and validate methods for the precise quantification and quality control of fluoroquinolone pharmaceuticals, ensuring high standards in drug manufacturing and compliance (Djurdjevic et al., 2009).
- Analysis Note: These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.
- Other Notes: Sales restrictions may apply.
SAFETY INFORMATION
Pictograms
Signal Word
Warning
Hazard Statements
Precautionary Statements
P261 - P264 - P271 - P280 - P302 + P352 - P305 + P351 + P338
Hazard Classifications
Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3
Target Organs
Respiratory system
WGK
WGK 2
Flash Point(F)
Not applicable
Flash Point(C)
Not applicable
Compare Similar Items
Show Difference
grade: pharmaceutical primary standard
API family: moxifloxacin
manufacturer/tradename: USP
application(s): pharmaceutical (small molecule)
format: neat
InChI: 1S/C20H21F2N3O3/c21-14-6-12-17(25(11-3-4-11)8-13(19(12)26)20(27)28)16(22)18(14)24-7-10-2-1-5-23-15(10)9-24/h6,8,10-11,15,23H,1-5,7,9H2,(H,27,28)/t10-,15+/m0/s1
InChI key: WEXQOLCYKFJAJZ-ZUZCIYMTSA-N
grade: pharmaceutical primary standard
API family: moxifloxacin
manufacturer/tradename: USP
application(s): pharmaceutical (small molecule)
format: neat
InChI: 1S/C20H22FN3O4/c21-14-6-12-16(24(11-3-4-11)8-13(18(12)25)20(27)28)19(26)17(14)23-7-10-2-1-5-22-15(10)9-23/h6,8,10-11,15,22,26H,1-5,7,9H2,(H,27,28)/t10-,15+/m0/s1
InChI key: IRASTQSQRDRSEH-ZUZCIYMTSA-N
grade: pharmaceutical primary standard
API family: moxifloxacin
manufacturer/tradename: USP
application(s): pharmaceutical (small molecule)
format: neat
InChI: __
InChI key: __
